,trial_id,trial_status,comp_date,last_updated,emails,results
0,JPRN-UMIN000039686,Open public recruiting,,2022-03-06,"['ecmoshingo@gmail.com', 'keiliu0406@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
1,JPRN-UMIN000039986,Main results already published,,2021-12-20,['horitano@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Please see:<br/>Risa Ebina-Shibuya et al. Respirology. 2020 Aug;25(8):898-899.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000039986</td>]"
2,JPRN-UMIN000040185,Enrolling by invitation,,2020-04-17,"['nobuhiro@z2.keio.jp', 'nobuhitotaniki@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
3,JPRN-UMIN000040188,Main results already published,,2021-12-20,['horitano@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Please see:<br/>J Thorac Dis. 2021 Jan;13(1):202-212. </td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
4,JPRN-UMIN000039873,Open public recruiting,,2021-03-24,['registry.covid@hosp.ncgm.go.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
5,JPRN-UMIN000040162,Completed,,2020-10-15,['rniikura@triton.ocn.ne.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
6,JPRN-UMIN000040193,No longer recruiting,,2022-04-20,['yosiyama@psy.med.osaka-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
7,JPRN-UMIN000040211,No longer recruiting,,2020-10-21,"['isatoshi0112@gmail.com', 'ogura@kanagawa-junko.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
8,JPRN-UMIN000040235,Completed,,2021-05-31,['horiitoshiki@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
9,JPRN-UMIN000040250,Terminated,,2021-02-06,['asezai.med@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
10,JPRN-UMIN000040278,Completed,,2021-05-01,"['kaku-ngs@umin.ac.jp', 'k-yanagi@nagasaki-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">This retrospective study evaluated stored nasopharyngeal swab samples from Japanese patients with influenza-like illness during the 2019/2020 season. We aimed to determine whether COVID-19 had spread in the community before the first confirmed case. When the first COVID-19 case was reported in Nagasaki prefecture, the number of influenza cases were very low. No positive results for SARS-CoV-2 were detected in 182 samples that were obtained from adult outpatients.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.sciencedirect.com/science/article/pii/S1286457921000344?via%3Dihub</td>]"
11,JPRN-UMIN000040286,Main results already published,,2021-11-01,['okuhara-ctr@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">The message from a physician increased participants intention to stay at home significantly more than other narrators messages.The message from a physician increased participants perceived severity, response efficacy, and self-efficacy significantly more than other narrators messages.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.sciencedirect.com/science/article/pii/S0738399120304432?via%3Dihub</td>]"
12,JPRN-UMIN000040289,Main results already published,,2020-11-15,['masafumi203@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
13,JPRN-UMIN000040295,Open public recruiting,,2020-05-02,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
14,JPRN-UMIN000040335,Preinitiation,,2020-05-08,['shinohara-t@takasaki-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
15,JPRN-UMIN000040401,Enrolling by invitation,,2020-05-14,['umemoto.cvm@tmd.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
16,JPRN-UMIN000039997,Completed,,2022-01-23,['ireef@jichi.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
17,JPRN-UMIN000040219,Main results already published,,2021-11-25,['takuma_h@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Ten doctors worked as Team COVID: seven internal medicine doctors and three surgeons. During the study period, Team COVID treated 165 individuals in the outpatient clinic and isolated hospitalized patients for 315 person-days. There were no positive results of serum-specific antibody testing and PCR testing for SARS-CoV-2 in Team COVID doctors. Furthermore, the SF-36 showed no deterioration in physical and mental QOL status. No in-hospital infection occurred during the study period.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">doi: 10.1016/j.jiph.2021.08.016.</td>]"
18,JPRN-UMIN000040333,No longer recruiting,,2021-11-08,['ikuro@matsuba-web.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">The 39 in 1603 subjects (2.4%) were found to be IgG antibody-positive: 29 in the patient group (2.9%), 10 in the doctor/nurse group (2.0%), and 0 in the control group. After adjustment for age, sex, and the antibody prevalence in the control group, antibody prevalence was 2.7% in the patient group and 2.1% in the doctor/nurse group.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.jiac-j.com/article/S1341-321X(20)30325-1/fulltext</td>]"
19,JPRN-UMIN000040341,Completed,,2021-09-11,"['nakamurachibiko@gmail.com', 'jimukyoku@takanawa-clinic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
20,JPRN-UMIN000040353,Terminated,,2020-05-26,['sagami1985@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
21,JPRN-UMIN000040405,Completed,,2021-05-07,['keiliu0406@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Currently under analysis</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
22,JPRN-UMIN000040407,Completed,,2021-09-11,"['nakamurachibiko@gmail.com', 'jimukyoku@takanawa-clinic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
23,JPRN-UMIN000040451,Preinitiation,,2020-05-22,"['katsuta-7-@marianna-u.ac.jp', 'naoki.shimizu@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
24,JPRN-UMIN000040453,No longer recruiting,,2021-11-18,['a24ogata@icloud.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
25,JPRN-UMIN000040479,Completed,,2021-09-11,"['nakamurachibiko@gmail.com', 'jimukyoku@takanawa-clinic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">L. plantarum showed the strikingly high innate cytokine index in all subjects in the in vitro cytokine response assay. In the subsequent trial, oral L. plantarum significantly increased the innate cytokine index and decreased the plasma level of IL-6. The cytokine index increased in 16 of 18 subjects with considerable individual differences in the fold change. In line with these innate cytokine changes, L. plantarum ingestion significantly enhanced the activity of natural killer cells.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Our findings will be opened to the public in a scientific paper.</td>]"
26,JPRN-UMIN000040516,Enrolling by invitation,,2020-05-26,['ohta.yuki@chiba-u.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
27,JPRN-UMIN000040520,No longer recruiting,,2020-06-03,['sagami1985@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Endoscopy is an aerosol generating procedure; quantitative proof was obtained</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
28,JPRN-UMIN000040563,Enrolling by invitation,,2020-05-28,['jnakata@juntendo.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
29,JPRN-UMIN000040587,Main results already published,,2021-11-25,['takuma_h@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Results: A total of 783 samples (560 upper GIE and 223 lower GIE samples) were analyzed. Polymerase chain reaction (PCR) on saliva samples did not show any positive results in either upper or lower GIE samples. However, 2.0% (16/783) of gastrointestinal fluid samples tested positive for SARS-CoV-2. No significant differences in age, sex, purpose of endoscopy, medication, or rate of antibody test positivity were found between PCR positive and PCR negative cases.<br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.1111/den.13945</td>]"
30,JPRN-UMIN000040598,Main results already published,,2021-06-01,['shingomatsumoto0606@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
31,JPRN-UMIN000040602,Completed,,2022-03-13,['ubiratanadler@ufscar.br'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Results showed that Natrum muriaticum LM2 was safe to use for COVID-19, but there was no statistically significant difference in the primary endpoints of Natrum muriaticum LM2 and placebo for mild COVID-19 cases. Although some secondary measures do not support the null hypothesis, the wide confidence intervals suggest that further studies with larger sample sizes and more symptomatic participants are needed to test the effectiveness of homeopathic Natrum muriaticum LM2 for COVID-19.<br/> <br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.1016/j.joim.2022.03.003</td>]"
32,JPRN-UMIN000040614,Enrolling by invitation,,2020-06-01,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
33,JPRN-UMIN000040616,Enrolling by invitation,,2020-06-01,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
34,JPRN-UMIN000040617,Enrolling by invitation,,2020-06-01,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
35,JPRN-UMIN000040679,No longer recruiting,,2020-12-08,['kaz-araki@gunma-cc.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
36,JPRN-UMIN000040683,Enrolling by invitation,,2021-05-14,"['tokitam-tky@umin.ac.jp', 'ashimazu-tky@umin.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
37,JPRN-UMIN000040694,Preinitiation,,2020-06-09,['nishikawa17635@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
38,JPRN-UMIN000004030,Terminated,,2012-02-13,[''],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
39,JPRN-UMIN000005451,Completed,,2011-06-05,[''],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
40,JPRN-UMIN000007147,Completed,,2013-05-17,[''],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
41,JPRN-UMIN000021203,Terminated,,2017-06-01,"['hiroaki.kato@medtronic.com', 'saka@med.nagoya-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
42,JPRN-UMIN000023311,No longer recruiting,,2021-01-31,['satoi@hirakata.kmu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">unpublished</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">unpublished</td>]"
43,JPRN-UMIN000026993,Completed,,2018-10-26,"['Ayumi.tsuchiya@medtronic.com', 'shoichiuezono@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
44,JPRN-UMIN000038838,Open public recruiting,,2021-06-11,"['akira.kikuchi@medtronic.com', 'aki.umetsu@medtronic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
45,JPRN-UMIN000040476,Enrolling by invitation,,2020-05-21,"['iyom@faculty.chiba-u.jp', 'sasaki@faculty.chiba-u.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
46,JPRN-UMIN000040409,Preinitiation,,2020-05-15,['cadmk@jikei.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
47,JPRN-UMIN000040733,Preinitiation,,2020-06-12,"['tsukinoki@kdu.ac.jp', 'handa@kdu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
48,JPRN-UMIN000040816,Preinitiation,,2020-06-17,['katsuta-7-@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
49,JPRN-UMIN000040838,Preinitiation,,2020-06-25,['ke-watanabe@hyo-med.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
50,JPRN-UMIN000040656,Preinitiation,,2020-06-04,"['hirarin95@yahoo.co.jp', 'hiropynakase@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
51,JPRN-UMIN000041021,Completed,,2022-05-19,"['meta.analysis.r@gmail.com', 'agoto@yokohama-ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
52,JPRN-UMIN000041073,Completed,,2021-06-26,"['defender8chan@yahoo.co.jp', 'ichirosekine@yahoo.co.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://onlinelibrary.wiley.com/doi/10.1002/ams2.603</td>]"
53,JPRN-UMIN000041102,Open public recruiting,,2021-11-25,['t-ueda@nakatsu.saiseikai.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
54,JPRN-UMIN000041160,Preinitiation,,2020-07-20,['kamei@slcn.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
55,JPRN-UMIN000041186,Enrolling by invitation,,2020-07-22,"['kfukunaga@keio.jp', 'ishii@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
56,JPRN-UMIN000041191,Open public recruiting,,2021-12-28,"['hiropynakase@gmail.com', 'k.wagatsuma@sapmed.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
57,JPRN-UMIN000041226,Enrolling by invitation,,2021-03-21,"['k-kimura@nms.ac.jp', 'nomo16@nms.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
58,JPRN-UMIN000041301,Enrolling by invitation,,2020-08-04,"['takayama@med.tohoku.ac.jp', 'akiko.kuwabara.d7@tohoku.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
59,JPRN-UMIN000040837,No longer recruiting,,2020-08-30,['somirai@tdc.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
60,JPRN-UMIN000041276,No longer recruiting,,2021-05-27,['hatakeyama-jik@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
61,JPRN-UMIN000041402,Preinitiation,,2020-08-13,"['hagiya@okayama-u.ac.jp', 'fumiotsu@okayama-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
62,JPRN-UMIN000041430,Open public recruiting,,2020-08-16,"['j.nugroho.eko@fk.unair.ac.id', 'eka.rahayu.utami@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
63,JPRN-UMIN000041450,Open public recruiting,,2020-08-18,"['nshime@hiroshima-u.ac.jp', 'ohshimos@hiroshima-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
64,JPRN-UMIN000041557,Preinitiation,,2020-08-26,['htomita@med.tohoku.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
65,JPRN-UMIN000041579,Completed,,2022-02-26,"['furuno.k@kd-research.com', 'hara.t@fcho.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Admissions for KD showed no significant change between April and May in 2015 to 2019 vs the same months in 2020. However, the number of admissions for droplet-transmitted or contact-transmitted respiratory tract infections decrease; and gastrointestinal infections showed significant decreases between April and May in 2015 to 2019 vs the same months in 2020.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">JAMA Netw Open. 2021;4(4):e214475. Published 2021 Apr 1. doi:10.1001/jamanetworkopen.2021.4475</td>]"
66,JPRN-UMIN000043369,Terminated,,2021-09-27,['shigekifujitani@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
67,JPRN-UMIN000040931,Completed,,2022-05-19,['meta.analysis.r@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
68,JPRN-UMIN000041168,No longer recruiting,,2022-04-03,"['ktakamatsu@kochi-u.ac.jp', 'ayokoyama@kochi-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
69,JPRN-UMIN000041387,No longer recruiting,,2021-10-01,"['koitomo@dokkyomed.ac.jp', 'kouhei-s@dokkyomed.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
70,JPRN-UMIN000041458,No longer recruiting,,2021-10-20,['kojima@opu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
71,JPRN-UMIN000041526,Completed,,2021-08-25,['kt.tkgw10pt@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
72,JPRN-UMIN000041705,Completed,,2021-03-12,['hisanori_masaki@eapharma.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">About 20% of eligible patients reduced their<br/>visit and 70% of them had not restored the f<br/>requency of visits. Their symptoms changed m<br/>ore widely than those who not. We identified<br/>longer duration of disease and higher medica<br/>l adherence score as the factors not reducin<br/>g visits. Few patients used telemedicine. A<br/>quarter of patients were recording their sy<br/>mptoms and they had higher medical adherence<br/>score.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">http://www.pieronline.jp/content/article/0386-3603/49010/17</td>]"
73,JPRN-UMIN000041893,No longer recruiting,,2021-03-27,"['editorial-jaam@umin.net', 'siris.accm@tmd.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
74,JPRN-UMIN000041227,No longer recruiting,,2020-10-29,"['agoto@yokohama-ac.jp', 'yamanaka@yokohama-cu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
75,JPRN-UMIN000041427,Completed,,2020-10-11,"['j.nugroho.eko@fk.unair.ac.id', 'eka.prasetya.budi-2017@fk.unair.ac.id']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Our meta-analysis showed that non-survivor group had lower platelet count compared to survivor group (SMD=-0.71 [95% CI: -1.01 to -0.41], p&lt;0.001; OR=3.89 [95%CI: 1.71 to 8.85], p=0.001); prolong PT (SMD=0.89 [95%CI: 0.35 to 1.43], p=0.001; OR=2.49 [95%CI: 1.00 to 6.20], p=0.05); prolong aPTT (SMD=0.33 [95%CI: -0.10 to 0.75], p=0.13); and increased INR (SMD=2.21 [95%CI: 0.10 to 4.31], p=0.04).</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
76,JPRN-UMIN000041769,No longer recruiting,,2022-03-14,"['k_nsm@yokohama-cu.ac.jp', 'itoshu@yokohama-cu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
77,JPRN-UMIN000041990,Completed,,2022-04-04,['harada@harbor.kobe-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Exercise behavior was promoted after the intervention in both intervention and waiting list groups.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">doi: 10.1007/s12529-021-10049-3</td>]"
78,JPRN-UMIN000042034,No longer recruiting,,2022-02-02,"['fujiya-1487@marianna-u.ac.jp', 'ryota.muroi@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
79,JPRN-UMIN000042052,Completed,,2020-10-08,"['Arya961mahendra@gmail.com', 'fauzikamal@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
80,JPRN-UMIN000042061,No longer recruiting,,2022-04-11,"['k-yamaga@md.tsukuba.ac.jp', 'hirayasu.kai@md.tsukuba.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
81,JPRN-UMIN000042106,No longer recruiting,,2022-04-22,"['hashinao@med.nagoya-u.ac.jp', 'ICARD.kokyuki@outlook.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
82,JPRN-UMIN000042142,Completed,,2020-11-06,"['taka.nakada@nifty.com', 'tamakichi.kuriken@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
83,JPRN-UMIN000042211,No longer recruiting,,2020-10-22,['reimzn@kuhp.kyoto-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
84,JPRN-UMIN000042235,Main results already published,,2021-05-21,"['noriyamada7@gmail.com', 'yyamashi@kuhp.kyoto-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
85,JPRN-UMIN000040349,Completed,,2022-05-12,['mari.saito@haga.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
86,JPRN-UMIN000040386,Enrolling by invitation,,2021-02-15,"['kaku-ngs@umin.ac.jp', 'k-yanagi@nagasaki-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
87,JPRN-UMIN000040402,Completed,,2021-05-15,"['kaku-ngs@umin.ac.jp', 'k-yanagi@nagasaki-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.medrxiv.org/content/10.1101/2021.03.10.21253064v3</td>]"
88,JPRN-UMIN000040539,Preinitiation,,2020-11-26,['kii.gast@tmd.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
89,JPRN-UMIN000040744,Completed,,2022-05-19,['johney@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
90,JPRN-UMIN000041421,Completed,,2022-04-11,['anomura@med.kanazawa-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Please see the manuscript via the link above</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://formative.jmir.org/2021/9/e30819/PDF</td>]"
91,JPRN-UMIN000041428,Completed,,2021-02-27,"['j.nugroho.eko@fk.unair.ac.id', 'maya.qurota.ayun-2019@fk.unair.ac.id']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">A total of 17 studies (1.654 patients) were included in this meta-analysis. It revealed a higher mean of fibrinogen levels on admission in patients with severe case when compared to non-severe case. Non-survivor group had a pooled higher mean difference of fibrinogen values on admission. Higher FDP on admission was found in poor outcome (composite of severity, critically ill, and mortality) compared to good outcome.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">DOI: 10.3233/CH-200978</td>]"
92,JPRN-UMIN000042076,Completed,,2021-07-17,"['eka.prasetya.budi-2017@fk.unair.ac.id', 'yusuf_505@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.1016/j.dsx.2021.102210</td>]"
93,JPRN-UMIN000042214,Open public recruiting,,2021-05-13,"['masakazumasakazu910@hotmail.co.jp', 't-sumiya@wakayama-med.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
94,JPRN-UMIN000042248,Open public recruiting,,2020-10-26,"['kirigaya@yokohama-cu.ac.jp', 'matsu@yokohama-cu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
95,JPRN-UMIN000042299,Enrolling by invitation,,2021-02-22,"['kfukunaga@keio.jp', 'ishii@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
96,JPRN-UMIN000042384,Completed,,2022-02-19,['yhiroshi@belle.shiga-med.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
97,JPRN-UMIN000042424,Completed,,2021-07-17,['eka.prasetya.budi-2017@fk.unair.ac.id'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Pooled prevalence of RVD in COVID-19 was 19% and PH was 22%. RVD and PH was associated with increased mortality, severity , ICU admission, and mechanical ventilation.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.5114/aoms/136342</td>]"
98,JPRN-UMIN000042453,Completed,,2020-11-14,"['arya961mahendra@gmail.com', 'fauzikamal@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
99,JPRN-UMIN000042477,Completed,,2021-10-10,['clatsune@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
100,JPRN-UMIN000042489,Completed,,2020-11-18,"['dr.ptk@mail.ru', 'kont07@yandex.ru']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
101,JPRN-UMIN000042522,Enrolling by invitation,,2021-02-20,['yshindo@med.nagoya-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
102,JPRN-UMIN000042270,No longer recruiting,,2022-02-02,"['fujiya-1487@marianna-u.ac.jp', 'kanaka@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
103,JPRN-UMIN000042599,Preinitiation,,2020-11-30,['y2nakamura@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
104,JPRN-UMIN000042681,No longer recruiting,,2020-12-07,['jp.haruna@hotmail.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
105,JPRN-UMIN000042717,No longer recruiting,,2021-06-14,"['koji.saito.e1@tohoku.ac.jp', 'yudai.i0213@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
106,JPRN-UMIN000042723,Enrolling by invitation,,2021-10-06,"['htomoya1979@hp-emerg.med.osaka-u.ac.jp', 'jumpei.y0210@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
107,JPRN-UMIN000042807,Preinitiation,,2020-12-22,"['yasuko.shinozaki.a1@tohoku.ac.jp', 'oshitanih@med.tohoku.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
108,JPRN-UMIN000042939,Completed,,2022-01-21,"['joshin@med.kagawa-u.ac.jp', 'kobara@med.kagawa-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
109,JPRN-UMIN000042919,Open public recruiting,,2021-01-05,"['faezezamanian@yahoo.com', 'f.zamanian@art.ac.ir']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
110,JPRN-UMIN000043167,Completed,,2022-02-07,"['yayoi.kawata@takeda.com', 'yoshihiko.furusawa@takeda.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
111,JPRN-UMIN000043256,Preinitiation,,2021-08-19,['sfujiki@med.niigata-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
112,JPRN-UMIN000043377,No longer recruiting,,2022-04-02,"['covidvac@juntendo.ac.jp', 'sito@juntendo.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.juntendo.ac.jp/jcrtc/about/results-of-activity/COVID19/covidresearch.html</td>]"
113,JPRN-UMIN000043367,Completed,,2022-03-29,['yyamada-kmm@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Excluding patients who died, the proportion of critical patients who could walk independently at discharge was 63%, and the proportion of those who were able to take <br/>three meals orally at discharge was 90%. Rehabilitation <br/>was provided to 13.4% of all patients, in particular to 58.3% of patients with critical symptoms.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://pubmed.ncbi.nlm.nih.gov/34896082/</td>]"
114,JPRN-UMIN000043400,Terminated,,2022-01-13,['kakeya@med.osaka-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
115,JPRN-UMIN000043403,Enrolling by invitation,,2022-02-24,"['hsaya@a6.keio.jp', 'rtakemura@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
116,JPRN-UMIN000043443,Open public recruiting,,2021-02-25,"['node@cc.saga-u.ac.jp', 'y-matsue@juntendo.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
117,JPRN-UMIN000043459,Completed,,2022-03-09,"['j.nugroho.eko@fk.unair.ac.id', 'eka.prasetya.budi-2017@fk.unair.ac.id']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">LMWH administration was associated with a lower in-hospital mortality, and 28/30-day mortality compared with UFH administration. However, there was no difference in the incidence of bleeding with LMWH compared with UFH.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
118,JPRN-UMIN000043530,Preinitiation,,2021-03-05,['oo0612@med.kawasaki-m.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
119,JPRN-UMIN000043537,Open public recruiting,,2021-03-05,"['hosam.refaei@yahoo.com', 'asmaa.elsaddory@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
120,JPRN-UMIN000043545,Enrolling by invitation,,2021-03-08,['ke-watanabe@hyo-med.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
121,JPRN-UMIN000043558,No longer recruiting,,2021-09-22,['kakugawa@yamaguchi-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
122,JPRN-UMIN000043566,No longer recruiting,,2021-05-13,"['masayok@ncgg.go.jp', 'yasuoka@ncgg.go.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
123,JPRN-UMIN000043622,Preinitiation,,2021-09-15,['registry.covid@hosp.ncgm.go.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
124,JPRN-UMIN000040672,Completed,,2021-12-24,"['koido.masaaki.gu@u.tsukuba.ac.jp', 'h.waki@thu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
125,JPRN-UMIN000043174,Completed,,2021-12-22,['kiepon@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Of the 245 eligible patients, there was no significant disability difference between baseline, pre-pandemic, and during the pandemic (p = 0.14). Similarly, pain intensity, health-related QOL, anxiety, depression, and the presence/absence of exercise habits did not significantly differ between baseline, pre-pandemic, and during the pandemic either. The current study observed significant differences in terms of catastrophic thinking (p = 0.02).</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://link.springer.com/article/10.1007/s00540-021-02992-y</td>]"
126,JPRN-UMIN000043350,No longer recruiting,,2022-02-21,"['keitay@hama-med.ac.jp', 'mmaekawa@hama-med.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Currently being analyzed</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
127,JPRN-UMIN000043368,Preinitiation,,2021-12-24,['takahiro-takazono@nagasaki-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
128,JPRN-UMIN000043369,Terminated,,2021-09-27,['shigekifujitani@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
129,JPRN-UMIN000043532,Preinitiation,,2021-03-10,"['toshinaga.tsuji@shionogi.co.jp', 'toru.nakai@shionogi.co.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
130,JPRN-UMIN000043534,Main results already published,,2022-03-07,['abetoshi111@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
131,JPRN-UMIN000043538,Completed,,2022-05-19,['ekato@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
132,JPRN-UMIN000043546,Completed,,2021-03-30,['anomura@med.kanazawa-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
133,JPRN-UMIN000043589,Preinitiation,,2021-03-11,['harameg@cc.saga-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
134,JPRN-UMIN000043671,Open public recruiting,,2021-07-10,['fbmtg-office@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
135,JPRN-UMIN000043769,Completed,,2022-02-28,['tsukinoki@kdu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
136,JPRN-UMIN000043788,Enrolling by invitation,,2021-03-30,['koga.yoko@twmu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
137,JPRN-UMIN000043802,Enrolling by invitation,,2021-04-01,"['kawakami@med.tohoku.ac.jp', 'kazu@med.toho-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
138,JPRN-UMIN000043820,Enrolling by invitation,,2021-10-13,"['kkazawa@hiroshima-u.ac.jp', 'sishii76@hiroshima-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
139,JPRN-UMIN000043821,Open public recruiting,,2021-04-02,['t-fukumori@naramed-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
140,JPRN-UMIN000043851,No longer recruiting,,2021-10-06,"['hdegawa@h2.dion.ne.jp', 'ponponta@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
141,JPRN-UMIN000043864,Completed,,2021-04-07,['keiliu0406@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
142,JPRN-UMIN000043867,Preinitiation,,2022-04-15,['sjinkun@hp-cqm.med.osaka-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
143,JPRN-UMIN000043873,No longer recruiting,,2021-04-09,['kentokuzuu@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
144,JPRN-UMIN000042556,No longer recruiting,,2021-05-24,"['kouima-tky@umin.ac.jp', 'norito@m.u-tokyo.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
145,JPRN-UMIN000043340,No longer recruiting,,2021-05-21,"['uwamino@keio.jp', 'wakuism@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
146,JPRN-UMIN000043830,Enrolling by invitation,,2022-04-03,['k-gucci@clin.medic.mie-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
147,JPRN-UMIN000044145,Preinitiation,,2022-02-09,['norito@m.u-tokyo.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
148,JPRN-UMIN000044213,Enrolling by invitation,,2021-05-14,['river.happiness@cick.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
149,JPRN-UMIN000044237,Main results already published,,2022-04-24,['sk513@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
150,JPRN-UMIN000044254,Preinitiation,,2021-05-24,"['daisuke_minakata_kappa@yahoo.co.jp', 'mitanik@dokkyomed.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
151,JPRN-UMIN000044261,Completed,,2022-02-05,['chiken@kamagaya-hp.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
152,JPRN-UMIN000044291,No longer recruiting,,2022-05-24,['kensukesumi@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
153,JPRN-UMIN000044332,No longer recruiting,,2021-11-24,['tishikawa@reposaka.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
154,JPRN-UMIN000044355,Preinitiation,,2021-07-13,['jun_kako@cna.u-hyogo.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
155,JPRN-UMIN000044435,Enrolling by invitation,,2021-12-06,"['satomura-r@tsurumi-u.ac.jp', 'tokuyama-r@tsurumi-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.mdpi.com/2075-4418/11/11/2024</td>]"
156,JPRN-UMIN000044456,Enrolling by invitation,,2021-06-07,['ahayashi@kitasato-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
157,JPRN-UMIN000044486,Completed,,2021-06-13,['y_kaji2012@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">In total, 25.1% subjects increased their alcohol intake and 24.5% subjects reduced their alcohol intake.<br/> <br/>Multivariate analysis identified only age (49 years or less) as a risk factor for increased drinking (adjusted odds ratio, 2.20; 95% confidence interval, 1.22-3.99; p = 0.009).</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
158,JPRN-UMIN000044519,Preinitiation,,2021-06-13,['nakayama.tomohiro@nihon-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
159,JPRN-UMIN000039686,Open public recruiting,"

2023
Year
08
Month
31
Day


",2022-03-06,"['ecmoshingo@gmail.com', 'keiliu0406@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
160,JPRN-UMIN000039986,Main results already published,"

2020
Year
03
Month
28
Day


",2021-12-20,['horitano@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Please see:<br/>Risa Ebina-Shibuya et al. Respirology. 2020 Aug;25(8):898-899.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000039986</td>]"
161,JPRN-UMIN000040185,Enrolling by invitation,"

2023
Year
03
Month
31
Day


",2020-04-17,"['nobuhiro@z2.keio.jp', 'nobuhitotaniki@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
162,JPRN-UMIN000040188,Main results already published,"

2021
Year
03
Month
31
Day


",2021-12-20,['horitano@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Please see:<br/>J Thorac Dis. 2021 Jan;13(1):202-212. </td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
163,JPRN-UMIN000039873,Open public recruiting,"

2022
Year
03
Month
31
Day


",2021-03-24,['registry.covid@hosp.ncgm.go.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
164,JPRN-UMIN000040162,Completed,"

2021
Year
03
Month
31
Day


",2020-10-15,['rniikura@triton.ocn.ne.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
165,JPRN-UMIN000040193,No longer recruiting,"

2021
Year
03
Month
31
Day


",2022-04-20,['yosiyama@psy.med.osaka-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
166,JPRN-UMIN000040211,No longer recruiting,"

2020
Year
06
Month
30
Day


",2020-10-21,"['isatoshi0112@gmail.com', 'ogura@kanagawa-junko.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
167,JPRN-UMIN000040235,Completed,"

2021
Year
04
Month
23
Day


",2021-05-31,['horiitoshiki@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
168,JPRN-UMIN000040250,Terminated,"

2020
Year
12
Month
31
Day


",2021-02-06,['asezai.med@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
169,JPRN-UMIN000040278,Completed,"

2021
Year
03
Month
31
Day


",2021-05-01,"['kaku-ngs@umin.ac.jp', 'k-yanagi@nagasaki-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">This retrospective study evaluated stored nasopharyngeal swab samples from Japanese patients with influenza-like illness during the 2019/2020 season. We aimed to determine whether COVID-19 had spread in the community before the first confirmed case. When the first COVID-19 case was reported in Nagasaki prefecture, the number of influenza cases were very low. No positive results for SARS-CoV-2 were detected in 182 samples that were obtained from adult outpatients.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.sciencedirect.com/science/article/pii/S1286457921000344?via%3Dihub</td>]"
170,JPRN-UMIN000040286,Main results already published,"

2020
Year
05
Month
14
Day


",2021-11-01,['okuhara-ctr@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">The message from a physician increased participants intention to stay at home significantly more than other narrators messages.The message from a physician increased participants perceived severity, response efficacy, and self-efficacy significantly more than other narrators messages.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.sciencedirect.com/science/article/pii/S0738399120304432?via%3Dihub</td>]"
171,JPRN-UMIN000040289,Main results already published,"

2020
Year
05
Month
08
Day


",2020-11-15,['masafumi203@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
172,JPRN-UMIN000040295,Open public recruiting,"

2021
Year
12
Month
31
Day


",2020-05-02,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
173,JPRN-UMIN000040335,Preinitiation,"

2021
Year
08
Month
31
Day


",2020-05-08,['shinohara-t@takasaki-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
174,JPRN-UMIN000040401,Enrolling by invitation,"

2025
Year
03
Month
31
Day


",2020-05-14,['umemoto.cvm@tmd.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
175,JPRN-UMIN000039997,Completed,"

2021
Year
03
Month
31
Day


",2022-01-23,['ireef@jichi.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
176,JPRN-UMIN000040219,Main results already published,"

2020
Year
10
Month
31
Day


",2021-11-25,['takuma_h@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Ten doctors worked as Team COVID: seven internal medicine doctors and three surgeons. During the study period, Team COVID treated 165 individuals in the outpatient clinic and isolated hospitalized patients for 315 person-days. There were no positive results of serum-specific antibody testing and PCR testing for SARS-CoV-2 in Team COVID doctors. Furthermore, the SF-36 showed no deterioration in physical and mental QOL status. No in-hospital infection occurred during the study period.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">doi: 10.1016/j.jiph.2021.08.016.</td>]"
177,JPRN-UMIN000040333,No longer recruiting,"

2021
Year
07
Month
30
Day


",2021-11-08,['ikuro@matsuba-web.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">The 39 in 1603 subjects (2.4%) were found to be IgG antibody-positive: 29 in the patient group (2.9%), 10 in the doctor/nurse group (2.0%), and 0 in the control group. After adjustment for age, sex, and the antibody prevalence in the control group, antibody prevalence was 2.7% in the patient group and 2.1% in the doctor/nurse group.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.jiac-j.com/article/S1341-321X(20)30325-1/fulltext</td>]"
178,JPRN-UMIN000040341,Completed,"

2020
Year
05
Month
16
Day


",2021-09-11,"['nakamurachibiko@gmail.com', 'jimukyoku@takanawa-clinic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
179,JPRN-UMIN000040353,Terminated,"

2020
Year
05
Month
20
Day


",2020-05-26,['sagami1985@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
180,JPRN-UMIN000040405,Completed,"

2021
Year
01
Month
30
Day


",2021-05-07,['keiliu0406@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Currently under analysis</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
181,JPRN-UMIN000040407,Completed,"

2020
Year
05
Month
20
Day


",2021-09-11,"['nakamurachibiko@gmail.com', 'jimukyoku@takanawa-clinic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
182,JPRN-UMIN000040451,Preinitiation,"

2021
Year
03
Month
31
Day


",2020-05-22,"['katsuta-7-@marianna-u.ac.jp', 'naoki.shimizu@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
183,JPRN-UMIN000040453,No longer recruiting,"

2023
Year
03
Month
31
Day


",2021-11-18,['a24ogata@icloud.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
184,JPRN-UMIN000040479,Completed,"

2020
Year
06
Month
30
Day


",2021-09-11,"['nakamurachibiko@gmail.com', 'jimukyoku@takanawa-clinic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">L. plantarum showed the strikingly high innate cytokine index in all subjects in the in vitro cytokine response assay. In the subsequent trial, oral L. plantarum significantly increased the innate cytokine index and decreased the plasma level of IL-6. The cytokine index increased in 16 of 18 subjects with considerable individual differences in the fold change. In line with these innate cytokine changes, L. plantarum ingestion significantly enhanced the activity of natural killer cells.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Our findings will be opened to the public in a scientific paper.</td>]"
185,JPRN-UMIN000040516,Enrolling by invitation,"

2023
Year
03
Month
31
Day


",2020-05-26,['ohta.yuki@chiba-u.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
186,JPRN-UMIN000040520,No longer recruiting,"

2020
Year
05
Month
20
Day


",2020-06-03,['sagami1985@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Endoscopy is an aerosol generating procedure; quantitative proof was obtained</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
187,JPRN-UMIN000040563,Enrolling by invitation,"

2023
Year
12
Month
31
Day


",2020-05-28,['jnakata@juntendo.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
188,JPRN-UMIN000040587,Main results already published,"

2020
Year
07
Month
31
Day


",2021-11-25,['takuma_h@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Results: A total of 783 samples (560 upper GIE and 223 lower GIE samples) were analyzed. Polymerase chain reaction (PCR) on saliva samples did not show any positive results in either upper or lower GIE samples. However, 2.0% (16/783) of gastrointestinal fluid samples tested positive for SARS-CoV-2. No significant differences in age, sex, purpose of endoscopy, medication, or rate of antibody test positivity were found between PCR positive and PCR negative cases.<br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.1111/den.13945</td>]"
189,JPRN-UMIN000040598,Main results already published,"

2023
Year
03
Month
31
Day


",2021-06-01,['shingomatsumoto0606@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
190,JPRN-UMIN000040602,Completed,"

2021
Year
04
Month
14
Day


",2022-03-13,['ubiratanadler@ufscar.br'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Results showed that Natrum muriaticum LM2 was safe to use for COVID-19, but there was no statistically significant difference in the primary endpoints of Natrum muriaticum LM2 and placebo for mild COVID-19 cases. Although some secondary measures do not support the null hypothesis, the wide confidence intervals suggest that further studies with larger sample sizes and more symptomatic participants are needed to test the effectiveness of homeopathic Natrum muriaticum LM2 for COVID-19.<br/> <br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.1016/j.joim.2022.03.003</td>]"
191,JPRN-UMIN000040614,Enrolling by invitation,"

2020
Year
12
Month
31
Day


",2020-06-01,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
192,JPRN-UMIN000040616,Enrolling by invitation,"

2020
Year
12
Month
31
Day


",2020-06-01,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
193,JPRN-UMIN000040617,Enrolling by invitation,"

2020
Year
12
Month
31
Day


",2020-06-01,['izumo_takehiro@med.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
194,JPRN-UMIN000040679,No longer recruiting,"

2021
Year
06
Month
07
Day


",2020-12-08,['kaz-araki@gunma-cc.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
195,JPRN-UMIN000040683,Enrolling by invitation,"

2022
Year
03
Month
30
Day


",2021-05-14,"['tokitam-tky@umin.ac.jp', 'ashimazu-tky@umin.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
196,JPRN-UMIN000040694,Preinitiation,"

2021
Year
03
Month
31
Day


",2020-06-09,['nishikawa17635@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
197,JPRN-UMIN000004030,Terminated,"

2012
Year
02
Month
01
Day


",2012-02-13,[''],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
198,JPRN-UMIN000005451,Completed,"

2010
Year
12
Month
01
Day


",2011-06-05,[''],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
199,JPRN-UMIN000007147,Completed,"

2013
Year
01
Month
31
Day


",2013-05-17,[''],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
200,JPRN-UMIN000021203,Terminated,,2017-06-01,"['hiroaki.kato@medtronic.com', 'saka@med.nagoya-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
201,JPRN-UMIN000023311,No longer recruiting,"

2018
Year
12
Month
31
Day


",2021-01-31,['satoi@hirakata.kmu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">unpublished</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">unpublished</td>]"
202,JPRN-UMIN000026993,Completed,"

2018
Year
05
Month
06
Day


",2018-10-26,"['Ayumi.tsuchiya@medtronic.com', 'shoichiuezono@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
203,JPRN-UMIN000038838,Open public recruiting,"

2021
Year
06
Month
30
Day


",2021-06-11,"['akira.kikuchi@medtronic.com', 'aki.umetsu@medtronic.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
204,JPRN-UMIN000040476,Enrolling by invitation,"

2021
Year
03
Month
31
Day


",2020-05-21,"['iyom@faculty.chiba-u.jp', 'sasaki@faculty.chiba-u.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
205,JPRN-UMIN000040409,Preinitiation,"

2022
Year
03
Month
31
Day


",2020-05-15,['cadmk@jikei.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
206,JPRN-UMIN000040733,Preinitiation,"

2022
Year
03
Month
31
Day


",2020-06-12,"['tsukinoki@kdu.ac.jp', 'handa@kdu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
207,JPRN-UMIN000040816,Preinitiation,"

2021
Year
03
Month
31
Day


",2020-06-17,['katsuta-7-@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
208,JPRN-UMIN000040838,Preinitiation,"

2022
Year
03
Month
31
Day


",2020-06-25,['ke-watanabe@hyo-med.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
209,JPRN-UMIN000040656,Preinitiation,"

2022
Year
03
Month
31
Day


",2020-06-04,"['hirarin95@yahoo.co.jp', 'hiropynakase@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
210,JPRN-UMIN000041021,Completed,"

2021
Year
07
Month
31
Day


",2022-05-19,"['meta.analysis.r@gmail.com', 'agoto@yokohama-ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
211,JPRN-UMIN000041073,Completed,"

2020
Year
09
Month
29
Day


",2021-06-26,"['defender8chan@yahoo.co.jp', 'ichirosekine@yahoo.co.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://onlinelibrary.wiley.com/doi/10.1002/ams2.603</td>]"
212,JPRN-UMIN000041102,Open public recruiting,"

2025
Year
03
Month
31
Day


",2021-11-25,['t-ueda@nakatsu.saiseikai.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
213,JPRN-UMIN000041160,Preinitiation,"

2023
Year
03
Month
31
Day


",2020-07-20,['kamei@slcn.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
214,JPRN-UMIN000041186,Enrolling by invitation,"

2030
Year
03
Month
31
Day


",2020-07-22,"['kfukunaga@keio.jp', 'ishii@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
215,JPRN-UMIN000041191,Open public recruiting,"

2022
Year
06
Month
30
Day


",2021-12-28,"['hiropynakase@gmail.com', 'k.wagatsuma@sapmed.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
216,JPRN-UMIN000041226,Enrolling by invitation,"

2022
Year
05
Month
31
Day


",2021-03-21,"['k-kimura@nms.ac.jp', 'nomo16@nms.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
217,JPRN-UMIN000041301,Enrolling by invitation,"

2021
Year
09
Month
30
Day


",2020-08-04,"['takayama@med.tohoku.ac.jp', 'akiko.kuwabara.d7@tohoku.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
218,JPRN-UMIN000040837,No longer recruiting,"

2020
Year
12
Month
31
Day


",2020-08-30,['somirai@tdc.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
219,JPRN-UMIN000041276,No longer recruiting,"

2022
Year
12
Month
31
Day


",2021-05-27,['hatakeyama-jik@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
220,JPRN-UMIN000041402,Preinitiation,"

2021
Year
03
Month
31
Day


",2020-08-13,"['hagiya@okayama-u.ac.jp', 'fumiotsu@okayama-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
221,JPRN-UMIN000041430,Open public recruiting,"

2020
Year
08
Month
16
Day


",2020-08-16,"['j.nugroho.eko@fk.unair.ac.id', 'eka.rahayu.utami@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
222,JPRN-UMIN000041450,Open public recruiting,"

2026
Year
03
Month
31
Day


",2020-08-18,"['nshime@hiroshima-u.ac.jp', 'ohshimos@hiroshima-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
223,JPRN-UMIN000041557,Preinitiation,"

2021
Year
03
Month
31
Day


",2020-08-26,['htomita@med.tohoku.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
224,JPRN-UMIN000041579,Completed,"

2020
Year
12
Month
31
Day


",2022-02-26,"['furuno.k@kd-research.com', 'hara.t@fcho.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Admissions for KD showed no significant change between April and May in 2015 to 2019 vs the same months in 2020. However, the number of admissions for droplet-transmitted or contact-transmitted respiratory tract infections decrease; and gastrointestinal infections showed significant decreases between April and May in 2015 to 2019 vs the same months in 2020.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">JAMA Netw Open. 2021;4(4):e214475. Published 2021 Apr 1. doi:10.1001/jamanetworkopen.2021.4475</td>]"
225,JPRN-UMIN000043369,Terminated,"

2023
Year
07
Month
31
Day


",2021-09-27,['shigekifujitani@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
226,JPRN-UMIN000040931,Completed,"

2021
Year
01
Month
31
Day


",2022-05-19,['meta.analysis.r@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
227,JPRN-UMIN000041168,No longer recruiting,"

2022
Year
03
Month
31
Day


",2022-04-03,"['ktakamatsu@kochi-u.ac.jp', 'ayokoyama@kochi-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
228,JPRN-UMIN000041387,No longer recruiting,"

2021
Year
03
Month
31
Day


",2021-10-01,"['koitomo@dokkyomed.ac.jp', 'kouhei-s@dokkyomed.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
229,JPRN-UMIN000041458,No longer recruiting,"

2021
Year
09
Month
01
Day


",2021-10-20,['kojima@opu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
230,JPRN-UMIN000041526,Completed,"

2020
Year
09
Month
30
Day


",2021-08-25,['kt.tkgw10pt@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
231,JPRN-UMIN000041705,Completed,"

2020
Year
09
Month
11
Day


",2021-03-12,['hisanori_masaki@eapharma.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">About 20% of eligible patients reduced their<br/>visit and 70% of them had not restored the f<br/>requency of visits. Their symptoms changed m<br/>ore widely than those who not. We identified<br/>longer duration of disease and higher medica<br/>l adherence score as the factors not reducin<br/>g visits. Few patients used telemedicine. A<br/>quarter of patients were recording their sy<br/>mptoms and they had higher medical adherence<br/>score.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">http://www.pieronline.jp/content/article/0386-3603/49010/17</td>]"
232,JPRN-UMIN000041893,No longer recruiting,"

2021
Year
09
Month
24
Day


",2021-03-27,"['editorial-jaam@umin.net', 'siris.accm@tmd.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
233,JPRN-UMIN000041227,No longer recruiting,"

2021
Year
12
Month
31
Day


",2020-10-29,"['agoto@yokohama-ac.jp', 'yamanaka@yokohama-cu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
234,JPRN-UMIN000041427,Completed,"

2020
Year
09
Month
15
Day


",2020-10-11,"['j.nugroho.eko@fk.unair.ac.id', 'eka.prasetya.budi-2017@fk.unair.ac.id']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Our meta-analysis showed that non-survivor group had lower platelet count compared to survivor group (SMD=-0.71 [95% CI: -1.01 to -0.41], p&lt;0.001; OR=3.89 [95%CI: 1.71 to 8.85], p=0.001); prolong PT (SMD=0.89 [95%CI: 0.35 to 1.43], p=0.001; OR=2.49 [95%CI: 1.00 to 6.20], p=0.05); prolong aPTT (SMD=0.33 [95%CI: -0.10 to 0.75], p=0.13); and increased INR (SMD=2.21 [95%CI: 0.10 to 4.31], p=0.04).</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
235,JPRN-UMIN000041769,No longer recruiting,"

2022
Year
09
Month
10
Day


",2022-03-14,"['k_nsm@yokohama-cu.ac.jp', 'itoshu@yokohama-cu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
236,JPRN-UMIN000041990,Completed,"

2021
Year
03
Month
31
Day


",2022-04-04,['harada@harbor.kobe-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Exercise behavior was promoted after the intervention in both intervention and waiting list groups.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">doi: 10.1007/s12529-021-10049-3</td>]"
237,JPRN-UMIN000042034,No longer recruiting,"

2024
Year
03
Month
31
Day


",2022-02-02,"['fujiya-1487@marianna-u.ac.jp', 'ryota.muroi@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
238,JPRN-UMIN000042052,Completed,"

2020
Year
05
Month
26
Day


",2020-10-08,"['Arya961mahendra@gmail.com', 'fauzikamal@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
239,JPRN-UMIN000042061,No longer recruiting,"

2021
Year
02
Month
28
Day


",2022-04-11,"['k-yamaga@md.tsukuba.ac.jp', 'hirayasu.kai@md.tsukuba.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
240,JPRN-UMIN000042106,No longer recruiting,"

2023
Year
03
Month
31
Day


",2022-04-22,"['hashinao@med.nagoya-u.ac.jp', 'ICARD.kokyuki@outlook.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
241,JPRN-UMIN000042142,Completed,"

2020
Year
05
Month
28
Day


",2020-11-06,"['taka.nakada@nifty.com', 'tamakichi.kuriken@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
242,JPRN-UMIN000042211,No longer recruiting,"

2020
Year
10
Month
15
Day


",2020-10-22,['reimzn@kuhp.kyoto-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
243,JPRN-UMIN000042235,Main results already published,"

2021
Year
02
Month
01
Day


",2021-05-21,"['noriyamada7@gmail.com', 'yyamashi@kuhp.kyoto-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
244,JPRN-UMIN000040349,Completed,"

2021
Year
11
Month
11
Day


",2022-05-12,['mari.saito@haga.jrc.or.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
245,JPRN-UMIN000040386,Enrolling by invitation,"

2023
Year
06
Month
30
Day


",2021-02-15,"['kaku-ngs@umin.ac.jp', 'k-yanagi@nagasaki-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
246,JPRN-UMIN000040402,Completed,"

2020
Year
06
Month
30
Day


",2021-05-15,"['kaku-ngs@umin.ac.jp', 'k-yanagi@nagasaki-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.medrxiv.org/content/10.1101/2021.03.10.21253064v3</td>]"
247,JPRN-UMIN000040539,Preinitiation,"

2025
Year
03
Month
31
Day


",2020-11-26,['kii.gast@tmd.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
248,JPRN-UMIN000040744,Completed,"

2020
Year
10
Month
31
Day


",2022-05-19,['johney@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
249,JPRN-UMIN000041421,Completed,"

2020
Year
11
Month
05
Day


",2022-04-11,['anomura@med.kanazawa-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Please see the manuscript via the link above</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://formative.jmir.org/2021/9/e30819/PDF</td>]"
250,JPRN-UMIN000041428,Completed,"

2020
Year
07
Month
25
Day


",2021-02-27,"['j.nugroho.eko@fk.unair.ac.id', 'maya.qurota.ayun-2019@fk.unair.ac.id']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">A total of 17 studies (1.654 patients) were included in this meta-analysis. It revealed a higher mean of fibrinogen levels on admission in patients with severe case when compared to non-severe case. Non-survivor group had a pooled higher mean difference of fibrinogen values on admission. Higher FDP on admission was found in poor outcome (composite of severity, critically ill, and mortality) compared to good outcome.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">DOI: 10.3233/CH-200978</td>]"
251,JPRN-UMIN000042076,Completed,"

2020
Year
10
Month
11
Day


",2021-07-17,"['eka.prasetya.budi-2017@fk.unair.ac.id', 'yusuf_505@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.1016/j.dsx.2021.102210</td>]"
252,JPRN-UMIN000042214,Open public recruiting,"

2025
Year
11
Month
14
Day


",2021-05-13,"['masakazumasakazu910@hotmail.co.jp', 't-sumiya@wakayama-med.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
253,JPRN-UMIN000042248,Open public recruiting,"

2030
Year
06
Month
30
Day


",2020-10-26,"['kirigaya@yokohama-cu.ac.jp', 'matsu@yokohama-cu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
254,JPRN-UMIN000042299,Enrolling by invitation,"

2030
Year
03
Month
31
Day


",2021-02-22,"['kfukunaga@keio.jp', 'ishii@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
255,JPRN-UMIN000042384,Completed,"

2021
Year
03
Month
31
Day


",2022-02-19,['yhiroshi@belle.shiga-med.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
256,JPRN-UMIN000042424,Completed,"

2020
Year
11
Month
11
Day


",2021-07-17,['eka.prasetya.budi-2017@fk.unair.ac.id'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Pooled prevalence of RVD in COVID-19 was 19% and PH was 22%. RVD and PH was associated with increased mortality, severity , ICU admission, and mechanical ventilation.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://doi.org/10.5114/aoms/136342</td>]"
257,JPRN-UMIN000042453,Completed,"

2020
Year
06
Month
10
Day


",2020-11-14,"['arya961mahendra@gmail.com', 'fauzikamal@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
258,JPRN-UMIN000042477,Completed,"

2021
Year
07
Month
01
Day


",2021-10-10,['clatsune@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
259,JPRN-UMIN000042489,Completed,"

2020
Year
06
Month
30
Day


",2020-11-18,"['dr.ptk@mail.ru', 'kont07@yandex.ru']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
260,JPRN-UMIN000042522,Enrolling by invitation,"

2023
Year
03
Month
31
Day


",2021-02-20,['yshindo@med.nagoya-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
261,JPRN-UMIN000042270,No longer recruiting,"

2024
Year
03
Month
31
Day


",2022-02-02,"['fujiya-1487@marianna-u.ac.jp', 'kanaka@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
262,JPRN-UMIN000042599,Preinitiation,"

2022
Year
03
Month
31
Day


",2020-11-30,['y2nakamura@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
263,JPRN-UMIN000042681,No longer recruiting,"

2020
Year
09
Month
30
Day


",2020-12-07,['jp.haruna@hotmail.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
264,JPRN-UMIN000042717,No longer recruiting,"

2021
Year
09
Month
30
Day


",2021-06-14,"['koji.saito.e1@tohoku.ac.jp', 'yudai.i0213@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
265,JPRN-UMIN000042723,Enrolling by invitation,"

2022
Year
12
Month
31
Day


",2021-10-06,"['htomoya1979@hp-emerg.med.osaka-u.ac.jp', 'jumpei.y0210@gmail.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
266,JPRN-UMIN000042807,Preinitiation,"

2021
Year
05
Month
31
Day


",2020-12-22,"['yasuko.shinozaki.a1@tohoku.ac.jp', 'oshitanih@med.tohoku.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
267,JPRN-UMIN000042939,Completed,"

2021
Year
12
Month
31
Day


",2022-01-21,"['joshin@med.kagawa-u.ac.jp', 'kobara@med.kagawa-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
268,JPRN-UMIN000042919,Open public recruiting,"

2021
Year
03
Month
30
Day


",2021-01-05,"['faezezamanian@yahoo.com', 'f.zamanian@art.ac.ir']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
269,JPRN-UMIN000043167,Completed,"

2021
Year
02
Month
26
Day


",2022-02-07,"['yayoi.kawata@takeda.com', 'yoshihiko.furusawa@takeda.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
270,JPRN-UMIN000043256,Preinitiation,"

2025
Year
03
Month
31
Day


",2021-08-19,['sfujiki@med.niigata-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
271,JPRN-UMIN000043377,No longer recruiting,"

2022
Year
03
Month
31
Day


",2022-04-02,"['covidvac@juntendo.ac.jp', 'sito@juntendo.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.juntendo.ac.jp/jcrtc/about/results-of-activity/COVID19/covidresearch.html</td>]"
272,JPRN-UMIN000043367,Completed,"

2021
Year
02
Month
15
Day


",2022-03-29,['yyamada-kmm@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Excluding patients who died, the proportion of critical patients who could walk independently at discharge was 63%, and the proportion of those who were able to take <br/>three meals orally at discharge was 90%. Rehabilitation <br/>was provided to 13.4% of all patients, in particular to 58.3% of patients with critical symptoms.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://pubmed.ncbi.nlm.nih.gov/34896082/</td>]"
273,JPRN-UMIN000043400,Terminated,"

2022
Year
12
Month
31
Day


",2022-01-13,['kakeya@med.osaka-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
274,JPRN-UMIN000043403,Enrolling by invitation,"

2022
Year
05
Month
31
Day


",2022-02-24,"['hsaya@a6.keio.jp', 'rtakemura@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
275,JPRN-UMIN000043443,Open public recruiting,"

2022
Year
03
Month
31
Day


",2021-02-25,"['node@cc.saga-u.ac.jp', 'y-matsue@juntendo.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
276,JPRN-UMIN000043459,Completed,"

2021
Year
08
Month
31
Day


",2022-03-09,"['j.nugroho.eko@fk.unair.ac.id', 'eka.prasetya.budi-2017@fk.unair.ac.id']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">LMWH administration was associated with a lower in-hospital mortality, and 28/30-day mortality compared with UFH administration. However, there was no difference in the incidence of bleeding with LMWH compared with UFH.</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
277,JPRN-UMIN000043530,Preinitiation,"

2025
Year
12
Month
31
Day


",2021-03-05,['oo0612@med.kawasaki-m.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
278,JPRN-UMIN000043537,Open public recruiting,"

2021
Year
02
Month
28
Day


",2021-03-05,"['hosam.refaei@yahoo.com', 'asmaa.elsaddory@yahoo.com']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
279,JPRN-UMIN000043545,Enrolling by invitation,"

2022
Year
03
Month
31
Day


",2021-03-08,['ke-watanabe@hyo-med.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
280,JPRN-UMIN000043558,No longer recruiting,"

2026
Year
03
Month
31
Day


",2021-09-22,['kakugawa@yamaguchi-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
281,JPRN-UMIN000043566,No longer recruiting,"

2021
Year
06
Month
30
Day


",2021-05-13,"['masayok@ncgg.go.jp', 'yasuoka@ncgg.go.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
282,JPRN-UMIN000043622,Preinitiation,"

2023
Year
06
Month
30
Day


",2021-09-15,['registry.covid@hosp.ncgm.go.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
283,JPRN-UMIN000040672,Completed,"

2020
Year
06
Month
30
Day


",2021-12-24,"['koido.masaaki.gu@u.tsukuba.ac.jp', 'h.waki@thu.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
284,JPRN-UMIN000043174,Completed,"

2022
Year
03
Month
31
Day


",2021-12-22,['kiepon@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Of the 245 eligible patients, there was no significant disability difference between baseline, pre-pandemic, and during the pandemic (p = 0.14). Similarly, pain intensity, health-related QOL, anxiety, depression, and the presence/absence of exercise habits did not significantly differ between baseline, pre-pandemic, and during the pandemic either. The current study observed significant differences in terms of catastrophic thinking (p = 0.02).</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://link.springer.com/article/10.1007/s00540-021-02992-y</td>]"
285,JPRN-UMIN000043350,No longer recruiting,"

2024
Year
03
Month
31
Day


",2022-02-21,"['keitay@hama-med.ac.jp', 'mmaekawa@hama-med.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">Currently being analyzed</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
286,JPRN-UMIN000043368,Preinitiation,"

2022
Year
12
Month
31
Day


",2021-12-24,['takahiro-takazono@nagasaki-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
287,JPRN-UMIN000043369,Terminated,"

2023
Year
07
Month
31
Day


",2021-09-27,['shigekifujitani@marianna-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
288,JPRN-UMIN000043532,Preinitiation,"

2021
Year
03
Month
22
Day


",2021-03-10,"['toshinaga.tsuji@shionogi.co.jp', 'toru.nakai@shionogi.co.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
289,JPRN-UMIN000043534,Main results already published,"

2022
Year
08
Month
31
Day


",2022-03-07,['abetoshi111@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
290,JPRN-UMIN000043538,Completed,"

2021
Year
12
Month
31
Day


",2022-05-19,['ekato@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
291,JPRN-UMIN000043546,Completed,"

2021
Year
03
Month
30
Day


",2021-03-30,['anomura@med.kanazawa-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
292,JPRN-UMIN000043589,Preinitiation,"

2023
Year
03
Month
31
Day


",2021-03-11,['harameg@cc.saga-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
293,JPRN-UMIN000043671,Open public recruiting,"

2023
Year
12
Month
31
Day


",2021-07-10,['fbmtg-office@umin.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
294,JPRN-UMIN000043769,Completed,"

2022
Year
03
Month
31
Day


",2022-02-28,['tsukinoki@kdu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
295,JPRN-UMIN000043788,Enrolling by invitation,"

2021
Year
04
Month
30
Day


",2021-03-30,['koga.yoko@twmu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
296,JPRN-UMIN000043802,Enrolling by invitation,"

2021
Year
09
Month
30
Day


",2021-04-01,"['kawakami@med.tohoku.ac.jp', 'kazu@med.toho-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
297,JPRN-UMIN000043820,Enrolling by invitation,"

2021
Year
12
Month
31
Day


",2021-10-13,"['kkazawa@hiroshima-u.ac.jp', 'sishii76@hiroshima-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
298,JPRN-UMIN000043821,Open public recruiting,"

2022
Year
03
Month
31
Day


",2021-04-02,['t-fukumori@naramed-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
299,JPRN-UMIN000043851,No longer recruiting,"

2021
Year
10
Month
07
Day


",2021-10-06,"['hdegawa@h2.dion.ne.jp', 'ponponta@marianna-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
300,JPRN-UMIN000043864,Completed,"

2021
Year
12
Month
31
Day


",2021-04-07,['keiliu0406@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
301,JPRN-UMIN000043867,Preinitiation,"

2023
Year
12
Month
31
Day


",2022-04-15,['sjinkun@hp-cqm.med.osaka-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
302,JPRN-UMIN000043873,No longer recruiting,"

2020
Year
12
Month
31
Day


",2021-04-09,['kentokuzuu@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
303,JPRN-UMIN000042556,No longer recruiting,"

2021
Year
03
Month
31
Day


",2021-05-24,"['kouima-tky@umin.ac.jp', 'norito@m.u-tokyo.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
304,JPRN-UMIN000043340,No longer recruiting,"

2025
Year
03
Month
31
Day


",2021-05-21,"['uwamino@keio.jp', 'wakuism@keio.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
305,JPRN-UMIN000043830,Enrolling by invitation,"

2026
Year
12
Month
31
Day


",2022-04-03,['k-gucci@clin.medic.mie-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
306,JPRN-UMIN000044145,Preinitiation,"

2022
Year
12
Month
31
Day


",2022-02-09,['norito@m.u-tokyo.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
307,JPRN-UMIN000044213,Enrolling by invitation,"

2022
Year
03
Month
31
Day


",2021-05-14,['river.happiness@cick.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
308,JPRN-UMIN000044237,Main results already published,"

2021
Year
07
Month
01
Day


",2022-04-24,['sk513@yokohama-cu.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
309,JPRN-UMIN000044254,Preinitiation,"

2022
Year
05
Month
31
Day


",2021-05-24,"['daisuke_minakata_kappa@yahoo.co.jp', 'mitanik@dokkyomed.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
310,JPRN-UMIN000044261,Completed,"

2021
Year
12
Month
28
Day


",2022-02-05,['chiken@kamagaya-hp.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
311,JPRN-UMIN000044291,No longer recruiting,"

2022
Year
05
Month
24
Day


",2022-05-24,['kensukesumi@gmail.com'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
312,JPRN-UMIN000044332,No longer recruiting,"

2021
Year
12
Month
31
Day


",2021-11-24,['tishikawa@reposaka.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
313,JPRN-UMIN000044355,Preinitiation,"

2023
Year
03
Month
31
Day


",2021-07-13,['jun_kako@cna.u-hyogo.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
314,JPRN-UMIN000044435,Enrolling by invitation,"

2021
Year
09
Month
30
Day


",2021-12-06,"['satomura-r@tsurumi-u.ac.jp', 'tokuyama-r@tsurumi-u.ac.jp']","[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">https://www.mdpi.com/2075-4418/11/11/2024</td>]"
315,JPRN-UMIN000044456,Enrolling by invitation,"

2023
Year
03
Month
31
Day


",2021-06-07,['ahayashi@kitasato-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
316,JPRN-UMIN000044486,Completed,"

2021
Year
04
Month
14
Day


",2021-06-13,['y_kaji2012@yahoo.co.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%"">In total, 25.1% subjects increased their alcohol intake and 24.5% subjects reduced their alcohol intake.<br/> <br/>Multivariate analysis identified only age (49 years or less) as a risk factor for increased drinking (adjusted odds ratio, 2.20; 95% confidence interval, 1.22-3.99; p = 0.009).</td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
317,JPRN-UMIN000044519,Preinitiation,"

2025
Year
03
Month
31
Day


",2021-06-13,['nakayama.tomohiro@nihon-u.ac.jp'],"[<td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>, <td align=""left"" bgcolor=""#E6E6FA"" colspan=""1"" rowspan=""1"" style=""word-wrap:break-word;"" width=""80%""><br/></td>]"
